News | July 27, 2021
Lasa production to commence in couple of weeks
The company is confident of commencing production at both Mahad and Chiplun units soon
The company is confident of commencing production at both Mahad and Chiplun units soon
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS
ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E
Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies
Subscribe To Our Newsletter & Stay Updated
